NCAM1 and graft versus host disease: Cytokine-induced killer cells (CIKs) are CD3+CD56+ T lymphocytes expanded in vitro that have cytotoxicity and tumor-homing capacity [1,2,3,4,5], without significant graft-versus-host disease (GvHD) [6,7,8,9].